BridgeMD
New treatment option for Achilles Tendinopathy (AT)
Official title Achilles Tendinopathy Embolization
ClinicalTrials.gov ID: NCT07477860
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn determine the feasibility of arterial embolization using Lipiodol emulsion to safely and effectively treat chronic Achilles tendon pain due to Achilles tendinopathy in adults aged 25 to 80. The main questions it aims to answer are: 1.
- Phase 1: an early, usually small safety study
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 80
You may be able to join if
- Age ≥ 25 years
- Subject provides written informed consent
- Patient with Achilles tendinopathy refractory to 3 months of conservative management
- Self reported pain of at least 4/10 on visual analog scale (VAS)
- Non-surgical candidate/looking to avoid surgery
You likely can't join if
- Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle/ligament injury, tendon rupture, and etiologies related...
- Steroid injection in the last 90 days from the embolization procedure
- Known severe allergy to Lipiodol and/or iodinated contrast media
- Diagnosis of peripheral arterial disease affecting the lower extremities
- Pregnancy or breastfeeding
- Anticoagulation or irreversible coagulopathy
See the full eligibility criteria
- Age ≥ 25 years
- Subject provides written informed consent
- Patient with Achilles tendinopathy refractory to 3 months of conservative management
- Self reported pain of at least 4/10 on visual analog scale (VAS)
- Non-surgical candidate/looking to avoid surgery
- Achilles tendon pain caused by acute fracture, recent trauma, inflammatory conditions, muscle/ligament injury, tendon rupture, and etiologies related to bone mineral density
- Steroid injection in the last 90 days from the embolization procedure
- Known severe allergy to Lipiodol and/or iodinated contrast media
- Diagnosis of peripheral arterial disease affecting the lower extremities
- Pregnancy or breastfeeding
- Anticoagulation or irreversible coagulopathy
- GFR \ 2.0 mg/dl
- Type 1 Diabetes Mellitus
The study team makes the final eligibility decision.
Where it's taking place
- Libertyville, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Libertyville, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.